Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old

被引:33
作者
Brookmeyer, Ron [1 ]
Kawas, Claudia H. [2 ,3 ,4 ]
Abdallah, Nada [1 ]
Paganini-Hill, Annlia [2 ]
Kim, Ronald C. [5 ]
Corrada, Maria M. [2 ,4 ,6 ]
机构
[1] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA
[2] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA
[4] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA
[5] Univ Calif Irvine, Med Ctr, Dept Pathol, Orange, CA USA
[6] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; Dementia; Intervention; Oldest-old; Pathology; Prediction; Prevalence; Prevention; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; AGE; COMMON; MODEL; RISK;
D O I
10.1016/j.jalz.2016.01.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The number of persons aged >90 years will grow significantly in coming decades. This group has the highest rates of dementia, most commonly Alzheimer's disease (AD). Methods: Using The 90+ Study, we developed a statistical model for dementia risk based on brain pathologies. Intervention scenarios which reduce or eliminate AD pathology were considered, and the numbers of dementia cases among the U.S. oldest-old that could be prevented were estimated. Results: The U.S. dementia prevalence among the oldest-old will increase from 1.35 million in 2015 to 4.72 million in 2050. If interventions eliminate AD pathology, dementia prevalence would be reduced by approximately 50%, averting nearly 2.4 million cases in 2050. However, large numbers of dementia cases would still remain. Discussion: Reducing AD pathology would significantly decrease the public health burden of dementia. However, other interventions are needed to address the burden associated with other dementing pathologies prevalent in the oldest-old. (C) 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 34 条
[31]   ESTIMATION AND INTERPRETATION OF ATTRIBUTABLE RISK IN HEALTH RESEARCH [J].
WALTER, SD .
BIOMETRICS, 1976, 32 (04) :829-849
[32]   Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target? [J].
Watt, Andrew D. ;
Crespi, Gabriela A. N. ;
Down, Russell A. ;
Ascher, David B. ;
Gunn, Adam ;
Perez, Keyla A. ;
McLean, Catriona A. ;
Villemagne, Victor L. ;
Parker, Michael W. ;
Barnham, Kevin J. ;
Miles, Luke A. .
ACTA NEUROPATHOLOGICA, 2014, 127 (06) :803-810
[33]   Recent clinical-pathologic research on the causes of dementia in late life: Update from the Honolulu-Asia Aging Study [J].
White, L ;
Small, BJ ;
Petrovitch, H ;
Ross, GW ;
Masaki, K ;
Abbott, RD ;
Hardman, J ;
Davis, D ;
Nelson, J ;
Markesbery, W .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2005, 18 (04) :224-227
[34]   Cerebrovascular pathology and dementia in autopsied Honolulu-Asia aging study participants [J].
White, L ;
Petrovitch, H ;
Hardman, J ;
Nelson, J ;
Davis, DG ;
Ross, GW ;
Masaki, K ;
Launer, L ;
Markesbery, WR .
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 :9-23